Yihui Deng

8PUBLICATIONS
4CO-AUTHORS
Predictive and prognostic markersMolecular targetsRespiratory diseasesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Pharmaceutical delivery technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Feb 26, 2024
Sialic Acid Conjugate-Modified Cationic Liposomal Paclitaxel for Targeted Therapy of Lung Metastasis in Breast Cancer: What a Difference the Cation Content Makes.

Wenliang Sun, Chao Han, Ruirui Ge

|Feb 24, 2023
A potential platform of combining sialic acid derivative-modified paclitaxel cationic liposomes with antibody-drug conjugates inspires robust tumor-specific immunological memory in solid tumors.

Wenliang Sun, Yantong Li, Dezhi Sui

|Jan 31, 2023
Minimalist Nanocomplex with Dual Regulation of Endothelial Function and Inflammation for Targeted Therapy of Inflammatory Vascular Diseases.

Shuo Wang, Yuequan Wang, Xiaoxue Lai

|Nov 16, 2022
Targeting Ibrutinib to Tumor-Infiltrating T Cells with a Sialic Acid Conjugate-Modified Phospholipid Complex for Improved Tumor Immunotherapy.

Cong Li, Chuizhong Fan, Shuang Lu

|Dec 21, 2019
Accelerated Blood Clearance of Nanoemulsions Modified with PEG-Cholesterol and PEG-Phospholipid Derivatives in Rats: The Effect of PEG-Lipid Linkages and PEG Molecular Weights.

Mengyang Liu, Yanyi Chu, Huan Liu

|Nov 06, 2018
Redox- and pH-Sensitive Glycan (Polysialic Acid) Derivatives and F127 Mixed Micelles for Tumor-Targeted Drug Delivery.

Mingqi Liu, Xiang Luo, Qiujun Qiu

Pageof 2

Frequent Collaborators

3 joint publications

Yanzhi Song

2 joint publications

Guoliang Chen

1 joint publications

Wenliang Sun

1 joint publications

Mingshi Yang